bf/NASDAQ:INSM_icon.png

NASDAQ:INSM

Insmed Incorporated

  • Stock

$

USD

Last Close

19.03

01/06 14:59

Market Cap

2.596B

Beta: 1.56

Volume Today

123K

Avg: 1.321M

PE Ratio

-5.73

PEG: -

OverviewFinancialsInsidersSenateAPIChart

  • industry

    Biotechnology

  • exchange

    NASDAQ Global Select

  • website

    www.insmed.com

  • ipo date

    Feb 15, 1991

  • full time employees

    613

  • currency

    USD

Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as ...Show More

Excel Tearsheet

Earnings

Earnings per Share (Estimate)

-1-0.50.512013-08-062015-08-062017-08-032019-08-012021-08-05

Revenue (Estimate)

10M20M30M40M50M60M70M2013-08-062015-08-062017-08-032019-08-012021-08-05

Related Tickers

markets.sh chat model as of Apr. 5 2023 results are not checked for accuracy. Please read the disclaimer.